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ABSTRACT
Objective: The present study was conducted to investigate the cytotoxicity and antimicrobial activity of zinc oxide nanoparticles (ZnO NPs) synthesized 
as eco-friendly technique from the leaf extract of Ipomoea pes-caprae (L.) R. Br. against human lung adenocarcinoma (A549), brain tumor (U87) cells, 
and human pathogens Salmonella typhi, Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, and Bacillus subtilis.
Materials and Methods: The work was carried out with varying precursor (plant extract) volume to optimize the synthesis of ZnO NPs and it 
was confirmed by ultraviolet (UV)-visible spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) analysis, scanning 
electron microscopy, and atomic force microscope (AFM) characterization techniques and evaluate its cytotoxicity activity by 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl--tetrazolium bromide assay method, antimicrobial activity by disk diffusion method.
Results: A peak at 320 nm with maximum intensity was observed at temperature of 80°C with pH of 8.0 in UV-visible spectroscopy confirmed the 
formation of ZnO NPs and we calculate the size of ZnO NPs from XRD data found as 15.8 nm. The FTIR analysis evaluated that the presence of different 
functional groups is carboxyl, amine, and phenolic compounds of leaves extract which are involved in the reduction of zinc ions and acts as capping 
the ZnO NPs. AFM microgram confirms that ZnO NPs were in nanorange and spherical in nature. The cytotoxicity activity of A549 and U87 cell lines 
treated with various concentrations of ZnO NPs showed a dose-dependent increase in cell inhibition and the half maximal inhibitory concentration 
value was calculated to be 7.8 µg/ml. The antibacterial activity of selected pathogens shows higher zone of inhibition.
Conclusion: The present study reveals that synthesized ZnO NPs capping with various bioactive compounds present in the leaf of I. pes-caprae show 
promising activity of cancer cell lines and antimicrobial agents; hence, further detailed study may lead to develop at a novel phytomedicine for the 
anticancer and antimicrobial drugs.
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INTRODUCTION
Recently, there is much focusing on natural products obtained from 
plants and herbal resources, Ipomoea pes-caprae consider as an example 
of phytocompounds richest resources. I. pes-caprae is used in flock 
medicine against inflammation and gastrointestinal disorder and as 
an analgesic agent [1]. I. pes-caprae is an ancient plant employed in the 
treatment of headache and various types of inflammation including 
jellyfish sting dermatitis [2]. In recent years, noble metal nanoparticles 
(NPs) have been the subjected of focused research due to their unique 
optical, electronic, mechanical, magnetic, and chemical properties that 
are significantly different from those of bulk materials [3]. Numerous 
approaches using plant extract have been used for the synthesis of metal 
NPs. The biosynthetic methodology employing plant extracts [4] has 
received much attention recently due to its simplicity, ecofriendliness, 
and economically viable nature, compared to the other existing methods 
such as using bacteria and fungi [5], and chemical [6] and physical 
methods used for synthesis of metal NPs. Zinc oxide NPs (ZnO NPs) 
have a tremendous potential in biological applications such as biological 
sensing [7], biological labeling, gene delivery, drug delivery [8], and 
nanomedicine along with its antibacterial [9], antifungal [10], acaricidal, 
pediculicidal, larvicidal [11], and antidiabetic activities [12]. ZnO NPs 
are known to be one of the multifunctional inorganic NPs with effective 
antibacterial activity [13]. Antibacterial and antifungal activities of ZnO 
NPs are observed even at very lower concentrations and the antifungal 
activity does not affect soil fertility compared to the conventional 
antifungal agents [14]. Based on literature, biosynthesis of ZnO NPs was 
reported using plant extracts including Aloe vera (leaf) [15], Nephelium 
lappaceum L. (fruit peel) [16], Corymbia citriodora (leaf) [17], Polygala 
tenuifolia (root) [18], Trifolium pratense (flower) [19], Rosa canina 
(fruit) [20], Zingiber officinale (rhizome) [21], Eucalyptus globulus (leaf) 
[22], and Vitex trifolia L. (leaf) [23]. Some reports show biosynthesized 
silver NPs from I. pes-caprae leaf extracts showed remarkable anticancer 
activity against liver cancer cells (A549) and human brain tumor cancer 
cell line (U87) and effective antibacterial activity [24].
In the present work, we tend to describe a green synthetic strategy to 
prepare ZnO NPs from leaves extract of I. pes-caprae. To confirm the 
presence of ZnO NPs, different characterization techniques were used 
and evaluate its cytotoxicity and antimicrobial activity of some selected 
cell lines and microbes.
MATERIALS AND METHODS
Chemicals, media, and cell line
Zinc acetate dihydrate (Zn (CH3COO)2.2H2O) was purchased from 
Sigma-Aldrich, Mumbai, India. High pure double distilled water was 
used throughout the method. Both normal and Whatman No.1 filter 
paper were used for the filtration process. The A549 and U87 cell lines 
were obtained from the National Centre for Cell Sciences (NCCS), Pune.
Preparation of plant extracts
Whole plant of I. pes-caprae was collected from Manakudi coastal area, 
Kanyakumari district, Tamil Nadu, India. The well-cleansed leaves were 
cut into smaller pieces using a sterilized knife thereafter allowed to dry 
in a hot air oven for 24 h at 40°C. The dried, cut leaves were removed 
from the oven and cooled down to room temperature before grinding 
using a mechanical grinder. The powdered leaves were collected and 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i5.32318
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filtered using mesh to collect very fine powder. The fine powders were 
then packed in airtight bags and keep for future use. From the fine 
powder, 5 g was weighed in a conical flask, to which 100 ml of double 
distilled water was poured into it. The mixture was refluxed using hot 
plate heated around 60°C for 1 h by stirring continuously to avoid 
evaporation. The extract obtained was then filtered out using Whatman 
filter paper, and the collected extract was kept in cold condition for the 
future synthesis process.
Phytosynthesis of ZnO NPs
About 20 ml of the plant extract was heated at 50°C for 10 min and 50 ml 
of 91 mM of zinc acetate solution (1 gm of zinc acetate was dissolved in 
50 ml of distilled water) was added dropwise to it under stirring. The 
reaction mixture became yellowish and cream-colored precipitate of 
zinc hydroxide was formed. The reaction mixture was left for 30 min for 
complete reduction to zinc hydroxide. Then, the precipitate was collected 
by centrifugation at 16,000 rpm for 10 min at 4°C. The precipitate was 
vacuum dried at 30°C and the pellet (ZnO NPs) was stored for further 
studies. Two other samples were prepared by varying the ratio of plant 
extract (10 ml and 30 ml) to zinc acetate (v/w) and were represented by 
the yield of ZnO, calculated using the following formula:
 Yield (%) =  (Experimental weight of ZnO/ 
Theoretical weight of ZnO)×100
Characterization of silver NPs
Ultraviolet (UV)-visible spectroscopy
The bioreduction of reaction mixture of the pure ZnO NPs was 
ascertained by observing the UV-visible spectroscopy at 200–800 nm 
using 1 ml of sample, compared with 1 ml of distilled water used as 
blank.
Fourier-transform infrared spectroscopy (FTIR)
To identify ZnO NPs associated biomolecules, the FTIR of powdered 
ZnO NPs was recorded on the Nicolet Avatar 660 FT-IR Spectroscopy 
using KBr pellets. To obtain better signal-to-noise ratio, 256 scans were 
taken in the range of 400–4000 cm−1 and the resolution was kept as 
4 cm−1.
X-ray diffraction (XRD)
The crystalline size and purity were characterized by X-ray 
diffractometer (Bruker D8 Advance) using Cu-Ka radiation of 
wavelength k= 1.541 A of synthesized ZnO NPs. The particle size of the 
prepared samples was determined using the Scherrer’s equation as 
follows: D≈0.9/cos θ, where, D is the crystal size, k is the wavelength 
of X-ray, h is the Braggs angle in radians, and B is the full width at half 
maximum (FWHM) of the peak in radians.
Scanning electron microscopy (SEM)
CARL ZEISS EVO18 SEM machine was used to characterize the 
morphology of ZnO NPs. Thin films of the sample were prepared on 
a carbon-coated copper grid by simply dropping a very small amount 
of the sample on the grid, extra solution was removed using a blotting 
paper, and then, the film on the SEM grid could dry by putting it under a 
mercury lamp for 5 min. The photographs were captured in SEM mode 
at the desired magnification.
Atomic force microscope (AFM) analysis
The synthesized NPs were spreading on the glass slides then dried and 
subjected for characterization to find morphological and structural 
properties by AFM AGILENT-N9410A-5500.
Biological application
Antibacterial activity
The antibacterial activity of the ZnO NPs was evaluated against 
Salmonella typhi, Staphylococcus aureus, Klebsiella pneumonia, 
Pseudomonas aeruginosa, and Bacillus subtilis using agar well diffusion 
method. The antibacterial effect of ZnO NPs has been reported against 
Gram-positive and Gram-negative bacteria due to larger surface area 
and electrostatic interaction of NPs. Stock cultures were maintained 
at 4°C on nutrient agar slant. Active cultures for experiments were 
prepared by transferring a loop full of culture from the stock cultures 
into the test tubes containing nutrient broth that was incubated at 24 h 
at 37°C. Antibacterial activity of extracts was determined by agar disc 
diffusion method on Mueller-Hinton agar (MHA) medium. MHA medium 
is poured into the Petri plate. Once the medium was solidified, the 
inoculums were spread on the solid plates with sterile swab moistened 
with the bacterial suspension. Different concentrations of the sample 
were prepared (1000 µg, 750 µg, and 500 µg). 20 µl of sample from 
each concentration was taken and added into the sterile discs and air 
dried. Then, the sample loaded disc was placed on the MHA plates 
along with positive control and incubated at 37°C for 24 h, and the 
antimicrobial activity was determined by measuring the diameter of 
zone of inhibition.
Cytotoxicity studies
Liver cancer cells (A549), and human brain tumor cancer (U87) 
cell lines were purchased from NCCS, Pune, India. It was cultured in 
Dulbecco’s modified Eagle’s Medium (DMEM, HiMedia Laboratories, 
Mumbai, India), supplemented with 10% fetal bovine serum and 
1% penicillin/streptomycin (HiMedia Laboratories, Mumbai, India). 
The cell lines were maintained at 5% CO2 in CO2 incubator. Cultures 
were examined using an inverted microscope to evaluate the quality 




To determine the cytotoxic effect of ZnO NPs synthesized from I. pes-
caprae leaves extract, cell viability study was carried out with the MTT 
reduction assay. A549 and U87 cells (1×105/well) were plated in 24-
well plates and incubated in 37°C with 5% CO2 condition. After the 
cell reaches the confluence, the various concentrations of the ZnO NPs 
were added and incubated for 24 h. After incubation, the sample was 
removed from the well and washed with phosphate-buffered saline 
(pH 7.4) or DMEM without serum. 100 µl/well (5 mg/ml) of 0.5% MTT 
was added and incubated for 4 h. After incubation, 1 ml of dimethyl 
sulfoxide (DMSO) was added in all the wells. The absorbance at 570 nm 
was measured with UV spectrophotometer using DMSO as the blank. 
Measurements were performed and the concentration required for 
a 50% inhibition (half maximal inhibitory concentration [IC50]) was 
determined graphically. The percentage of cell viability was calculated 
using the following formula:
O.D of treated cellsPercentage of cell viability= 100
O.D of control cells

Graphs were plotted using the percentage of cell viability at Y-axis and 
concentration of the sample in X-axis. Cell control and sample control 
are included in each assay to compare the full cell viability assessments.
RESULTS AND DISCUSSION
Effect of plant extract concentration on ZnO NP synthesis
Concentration of plant extract plays a key role in the synthesis of ZnO 
NPs. It has been observed that the ratio of plant extract to zinc acetate 
20 ml/gm (i.e., 1 gm of zinc acetate in 20 ml of plant extract) was optimal 
concentration for the synthesis of ZnO NPs which gives yield 95%. 
Insufficient amount of bioactive compound present in 10 ml/gm of zinc 
acetate lowers the yield of ZnO NPs gives 70%, whereas 30 ml/gm of 
zinc acetate yield 95% nearly same amounts of ZnO NPs that yield in 
20 ml/gm (Fig. 1). That means, the number of bioactive compounds 
present in case of 20 ml/gm was sufficient to reduce all Zn2+ ions 
present in the reaction mixture.
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Characterization of synthesized ZnO NPs
UV-visible spectrum
UV-visible spectroscopy used to identify the synthesis of ZnO NPs 
(Fig. 2) represents the formation of ZnO NPs. Freshly prepared ZnO 
suspensions in plant extract exhibit a strong absorption at 320 nm in 
the UV region. This surface plasmon resonance band undergoes a red 
or blue shift, depending on the quantum size effects. The absorbance 
of ZnO NPs depends on their shape and size. The plant extract reacts 
with Zn2+ ions reduces the precursor solution and formation of NPs 
monitored by UV-visible spectroscopy.
FTIR analysis
The FTIR spectrum of I. pes-caprae leaves extract and synthesized ZnO 
NPs (Fig. 3) showed strong IR bands characteristic of carboxylic acids 
(1030 cm−1), amines (1622 cm−1), alkanes (2923 and 2853 cm−1), O-H 
carboxylic acids (2362 cm−1), and hydrogen bonded alcohols (3416 cm−1) 
functional groups. The band at 3424.94 cm−1 that corresponds to normal 
“polymeric” OH stretching mode. The peak at 2923cm−1 associated to 
the methylene C-H asymmetric and symmetric stretching mode. The 
peak at 2362 cm−1 indicates the symmetric stretching of alkanes and 
the peak at 1622 cm−1 attributed to the C=O stretching mode of ketones. 
The peak at 1384 cm−1 corresponds to the N=O stretching of nitro 
groups of leaves extract. Here, we confirm the modulated transmittance 
percentage of ketone, polymeric OH compounds, and amine groups play 
a key role for the bioreduction of Zn2+ to ZnO NPs. The FTIR analysis 
strongly supported the capping behavior of bioreduced ZnO NPs 
synthesized by I. pes-caprae leaves extracts which, in turn, imparted the 
high stability of the synthesized NPs.
XRD analysis
The XRD spectra of I. pes-caprae leaf aqueous extract mediated ZnO NPs 
are shown in Fig. 4. The prominent peaks corresponding to the diffraction 
planes (100), (002), (101), (012), (102), (110), (103), (200), (112), (201), 
and (202) agreed well with the JCPDS Card No. 36-1451, confirming the 
hexagonal wurtzite structure of the ZnO NPs. The strong intensity and 
broadened diffraction peaks clearly indicate that the ZnO NPs are highly 
crystalline in nature. Similar results are obtained by Yu et al. [25]. The 
average particle size (D) of synthesized NPs was calculated using the 
well-known Scherrer formula D=0.9 k/b cos θ, where, k is the wavelength 
of X-ray source (Cu-Ka line – 0.1541 nm), b is the FWHM in radians, and h 
is Bragg’s diffraction angle. The calculated value of D was 15.8 nm.
SEM
The shape, structure, and size of the ZnO NP synthesized using leaf 
extracts of I. pes-caprae was determined by the SEM analysis (Fig. 5) and 
an average size of about 27 nm was seen in the ZnO NP. The previous 
studies showed that the ZnO NPs were in the range of 37 nm and these 
were in accordance to our present study [26].
AFM
The AFM of 2D and 3D result images that shown in Fig. 6 showed the 
morphological and structural characterization of green synthesized 
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Fig. 2: Ultraviolet-visible absorption spectrum of zinc oxide 
nanoparticles synthesized from Ipomoea pes-caprae leaves 
extract
Fig. 3: Fourier-transform infrared spectroscopy spectrum of synthesized zinc oxide nanoparticles
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Fig. 4: X-ray diffraction spectra of zinc oxide nanoparticles using Ipomoea pes-caprae leaves aqueous extract
Fig. 5: Scanning electron microscopy images of zinc oxide 
nanoparticles using Ipomoea pes-caprae leaves extract
ZnO NPs by I. pes-caprae leaves extract with average diameter of 
40 nm. From the figure concluded that NPs are equal in size and their 
morphology also rough in nature cubical in shape.
Biological applications of ZnO NPs
Antibacterial activity
Synthesized ZnO NPs were analyzed by disk diffusion method using 
selected organisms such as S. typhi, S. aureus, K. pneumonia, P. aeruginosa, 
and B. Subtilis is shown in Fig.7. As the concentration of ZnO NPs increases, 
the zone of inhibition also increased against the bacteria strain is shown 
in Table 1. ZnO NPs synthesized from leaves extract exhibited significant 
activity against S. typhi and P. aeruginosa with zone of inhibition 20 and 
15 mm is shown in Fig.8. This proves that the ZnO NPs synthesized by the 
simple solution method may be used for microbial activity study.
Finally, the current study clearly indicates that the synthesized ZnO 
NPs exhibit the zone of inhibition have high value obtained at Gram-
negative organisms of S. typhi and P. aeruginosa. These plant-mediated 
ZnO NPs show high antibacterial activity which may be used in textiles 
coatings and wood flooring as antibacterial agents.
Table 1: Antibacterial activity of the ZnO NPs synthesized by I. pes-caprae leaves extract
Bacterium name Zone of inhibition (mm)
Control (ampicillin) 1000 µg/mL 1000 µg/ml 750 µg/ml 500 µg/ml
Staphylococcus aureus 21 11 9 9
Bacillus subtilis 23 12 9 8
Klebsiella pneumoniae 18 13 10 9
Salmonella typhi 47 20 11 9
Pseudomonas aeruginosa 25 15 11 10
I. pes-caprae: Ipomoea pes-caprae, ZnO NPs: Zinc oxide nanoparticles
Table 2: Cytotoxicity activity of the ZnO NPs synthesized by I. pes-caprae leaves extract
S. No. Concentration (µg/ml) Dilution Absorbance (O.D) Cell viability (%)
A549 U87 A549 U87
1 1000 Neat 0.116 0.082 11.98 11.76
2 500 1:1 0.162 0.109 16.73 15.63
3 250 1:2 0.211 0.135 21.79 19.36
4 125 1:4 0.264 0.172 27.27 24.67
5 62.5 1:8 0.326 0.212 33.67 30.41
6 31.2 1:16 0.389 0.246 40.18 35.29
7 15.6 1:32 0.453 0.286 46.79 41.03
8 7.8 1:64 0.512 0.338 52.89 48.49
9 Cell control 0.968 0.697 100 100
I. pes-caprae: Ipomoea pes-caprae, ZnO NPs: Zinc oxide nanoparticles
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Fig. 6: Atomic force microscope images of zinc oxide nanoparticles synthesized by Ipomoea pes-caprae leaf extract
Fig. 8: Effect of antibacterial activity of zinc oxide nanoparticles 
from leaves extract with positive control
Fig. 9: Anticancer activity of zinc oxide nanoparticles from leaves 
extract of Ipomoea pes-caprae in A549 cell line ([1] Normal A549 
cell line, [2] Toxicity – 1000 µg/ml, [3] Toxicity – 62.5 µg/ml, and 
[4] Toxicity – 7.8 µg/ml)
Fig. 7: The antibacterial activity of zinc oxide nanoparticles from 
leaves extract in (a) Staphylococcus aureus, (b) Bacillus subtilis 
(c) Klebsiella pneumonia, (d) Salmonella typhi, (e) Pseudomonas 
aeruginosa, at various concentrations ([1] Positive control, [2] 
500 µg/ml, [3] 750 µg/ml, and [4] 1000 µg/ml)
Cytotoxicity analysis
The cytotoxicity of the ZnO NPs synthesized from I. pes-caprae leaves 
extract was studied against the A549 (Fig. 9) and U87 (Fig. 10) cell 
line by MTT assay. The cytotoxicity effect of cancer cell was studied at 
different concentrations (1000 μg/ml–7.8 μg/ml) is shown in Table 2. 
The IC50 value of the phyto-mediated ZnO NPs of leaves extract at the 
cell viability of 52.9% (Fig. 11) against A549 cells was observed at 7.8 
μg/ml and for U87 cells was observed as 48.5% at the concentration of 
7.8 μg/ml (Fig. 12). This study shows that the minimum dose showed 
significant anticancer activity. Some reports exhibit that ZnO NPs 
may stimulate reactive oxygen species and effect in damage cellular 
components which lead to cell death [27]. Some reports show that ZnO 
NPs were induced greater cytotoxicity in the colon, liver, lung, and skin 
cells at higher concentrations of 100 and 300 μg/ml significantly [28].
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CONCLUSION
We report a simple straight forward, facile, inexpensive, eco-friendly, 
and green synthesis of ZnO NPs from I. pes-caprae leaves in aqueous 
medium without employing man-made chemicals. The UV-visible 
spectroscopy and FT-IR analysis are confirmed the preliminary 
confirmation of the formation of ZnO NPs. AFM image showed cubical 
shape with an average particle size of 40 nm. The biosynthesized ZnO 
NPs from I. pes-caprae leaf extracts showed remarkable anticancer 
activity against liver cancer cells (A549) and human brain tumor cancer 
cell line (U87) and effective antibacterial activity. From the study, it 
can be concluded that the ZnO NPs synthesized using plant possess 
high anticancer and antibacterial activity which further suggested the 
potential therapeutic use of these NPs.
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Fig. 11: Half maximal inhibitory concentration value of zinc oxide 

















Fig. 12: Half maximal inhibitory concentration value of zinc oxide 
nanoparticles from leaves extract against U87 cell line
Fig. 10: Anticancer activity of zinc oxide nanoparticles from 
leaves extract of Ipomoea pes-caprae in U87 cell line ([1] Normal 
U87 cell line, [2] Toxicity – 1000 µg/ml, [3] Toxicity – 62.5 µg/ml, 
and [4] Toxicity – 7.8 µg/ml)
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